# Impact of Concomitant Genetic Alterations in EGFR Mutated Adenocarcinoma by NGS Analysis: A Multicenter Study

> **NCT04122833** · — · UNKNOWN · sponsor: **Konkuk University Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Adenocarcinoma of Lung
- EGFR Activating Mutation

## Interventions

- **OTHER:** Next generation sequencing

## Key facts

- **NCT ID:** NCT04122833
- **Lead sponsor:** Konkuk University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-30
- **Primary completion:** 2023-09-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-08-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04122833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04122833, "Impact of Concomitant Genetic Alterations in EGFR Mutated Adenocarcinoma by NGS Analysis: A Multicenter Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04122833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*